[go: up one dir, main page]

AU1762092A - Circumsporozoite protein of plasmodium reichenowi and vaccine for human malaria - Google Patents

Circumsporozoite protein of plasmodium reichenowi and vaccine for human malaria

Info

Publication number
AU1762092A
AU1762092A AU17620/92A AU1762092A AU1762092A AU 1762092 A AU1762092 A AU 1762092A AU 17620/92 A AU17620/92 A AU 17620/92A AU 1762092 A AU1762092 A AU 1762092A AU 1762092 A AU1762092 A AU 1762092A
Authority
AU
Australia
Prior art keywords
vaccine
circumsporozoite protein
human malaria
plasmodium reichenowi
reichenowi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17620/92A
Inventor
Ira F Goldman
Altaf A Lal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United States Department of Commerce
Original Assignee
Government of the United States of America
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Government of the United States of America filed Critical Government of the United States of America
Publication of AU1762092A publication Critical patent/AU1762092A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU17620/92A 1991-04-01 1992-04-01 Circumsporozoite protein of plasmodium reichenowi and vaccine for human malaria Abandoned AU1762092A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67753991A 1991-04-01 1991-04-01
US677539 1991-04-01

Publications (1)

Publication Number Publication Date
AU1762092A true AU1762092A (en) 1992-11-02

Family

ID=24719123

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17620/92A Abandoned AU1762092A (en) 1991-04-01 1992-04-01 Circumsporozoite protein of plasmodium reichenowi and vaccine for human malaria

Country Status (2)

Country Link
AU (1) AU1762092A (en)
WO (1) WO1992017204A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL144750A0 (en) * 1999-02-18 2002-06-30 Rmf Dictagene Sa Malaria vaccine
WO2012154199A1 (en) 2010-10-18 2012-11-15 The Government Of The United States, As Represented By The Secretary Of The Army Soluble recombinant plasmodium falciparum circumsporozoite protein
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
US9321834B2 (en) * 2013-12-05 2016-04-26 Leidos, Inc. Anti-malarial compositions

Also Published As

Publication number Publication date
WO1992017204A1 (en) 1992-10-15

Similar Documents

Publication Publication Date Title
GB9207363D0 (en) Improved use of b2 bronchodilator drugs
PL311036A1 (en) Method of obtaining an anticarcinogenic vaccine
PL326756A1 (en) Anticarcinogenic vaccine and method of obtaining same
AU4028895A (en) Vaccine and treatment method of Human Immunodeficiency Virus
IL99851A0 (en) Muramyldipeptide derivatives and influenza vaccine containing them
AU5293486A (en) Malaria vaccine against plasmodium falciparum
NZ223174A (en) Peptides and multimers immunologically related to circumsporozoite protein; vaccines against plasmodium falciparum-induced malaria
AU1818200A (en) Chromosome 2 sequence of the human malaria parasite (plasmodium falciparum) and proteins of said chromosome useful in anti-malarial vaccines and diagnostic reagents
AU1762092A (en) Circumsporozoite protein of plasmodium reichenowi and vaccine for human malaria
AU2992489A (en) Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum
AU6777490A (en) Malaria vaccine
AUPM368994A0 (en) Malaria merozoite antigen subunit vaccine
AU1203092A (en) Protective malaria sporozoite surface protein immunogen and gene
AU5851296A (en) Malaria peptides and vaccines
IL78476A0 (en) Highly repetitive antigens of plasmodium falciparum
AU3069989A (en) Rhoptry membrane antigen of plasmodium falciparum
AU2609588A (en) Rhoptry antigen of plasmodium falciparum
ZA901757B (en) Plasmodium merozoite rhoptries antigen and derivatives thereof
AU6687786A (en) Asexual blood stage antigens of plasmodium falciparum
AU3076592A (en) Malarial vaccine and peptides comprising human t-cell epitope of circumsporozoite protein of (p.vivax)
AU5450590A (en) Malaria vaccine
AU637468B2 (en) Plasmodium sporozoite antigen
AU7163091A (en) Novel malarial sporozoite peptide antigens
GB9102294D0 (en) Antigen of plasmodium falciparum
AU7699887A (en) Merozoite surface antigen of plasmodium falciparum